Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model
Introduction. Treatment of open fractures routinely involves multiple surgeries and delayed definitive fracture fixation because of concern for infection. If implants were made less susceptible to infection, a one-stage procedure with intramedullary nailing would be more feasible, which would reduce...
Main Authors: | A. I. Stavrakis, S. Zhu, A. H. Loftin, X. Weixian, J. Niska, V. Hegde, T. Segura, N. M. Bernthal |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/1638508 |
Similar Items
-
Identification of tigecycline- and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran
by: M. Yousefi, et al.
Published: (2017-09-01) -
Point-of-care antimicrobial coating protects orthopaedic implants from bacterial challenge
by: Weixian Xi, et al.
Published: (2021-09-01) -
Diabetic mouse model of orthopaedic implant-related Staphylococcus aureus infection.
by: Arianna B Lovati, et al.
Published: (2013-01-01) -
Evaluating vancomycin susceptibility in Staphylococcus aureus
by: Mimica MJ, et al.
Published: (2016-09-01) -
Vancomycin Promotes the Bacterial Autolysis, Release of Extracellular DNA, and Biofilm Formation in Vancomycin-non-Susceptible Staphylococcus aureus.
by: Chi Yu Hsu, et al.
Published: (2012)